4.7 Review

When less is more: the forbidden fruits of gene repression in the adult β-cell

Journal

DIABETES OBESITY & METABOLISM
Volume 15, Issue 6, Pages 503-512

Publisher

WILEY
DOI: 10.1111/dom.12029

Keywords

gene profile; insulin secretion; type 2 diabetes; beta-cell

Funding

  1. Wellcome Trust Programme [081958/Z/07/Z]
  2. WellcomeTrust Senior Investigator [WT098424AIA]
  3. Royal Society Wolfson Research Merit Award

Ask authors/readers for more resources

Outside of the biological arena the term repression' often has a negative connotation. However, in the pancreatic -cell a small group of genes, which are abundantly expressed in most if not all other mammalian tissues, are highly selectively repressed, with likely functional consequences. The two founder' members of this group, lactate dehydrogenase A (Ldha) and monocarboxylate transporter-1 (MCT-1/Slc16a1), are inactivated by multiple mechanisms including histone modifications and microRNA-mediated silencing. Their inactivation ensures that pyruvate and lactate, derived from muscle during exercise, do not stimulate insulin release inappropriately. Correspondingly, activating mutations in the MCT-1 promoter underlie exercise-induced hyperinsulinism' (EIHI) in man, a condition mimicked by forced over-expression of MCT-1 in the -cell in mice. Furthermore, LDHA expression in the -cell is upregulated in both human type 2 diabetes and in rodent models of the disease. Recent work by us and by others has identified a further approximate to 60 genes which are selectively inactivated in the -cell, a list which we refine here up to seven by detailed comparison of the two studies. These genes include key regulators of cell proliferation and stimulus-secretion coupling. The present, and our earlier results, thus highlight the probable importance of shutting down a subset of disallowed' genes for the differentiated function of -cells, and implicate previously unsuspected signalling pathways in the control of -cell expansion and insulin secretion. Targeting of deregulated disallowed' genes in these cells may thus, in the future, provide new therapeutic avenues for type 2 diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available